surmount-1 tirzepatide weight loss percent nejm 2022 Presented at ECO 2025: In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, was superior to semaglutide in reducing body and waist circumference. Full trial Tirzepatide: In the SURMOUNT-1 trial,
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14


















![Cynthia - 119a/156 (Regional Championships) [Staff]/156 - Reverse Holofoil League & Championship Cards - Promo SH4](https://cdn.shopify.com/s/files/1/0561/0376/4010/files/198219_3e742165-8033-4016-9552-ed79cc70abcc.jpg?v=1781121947)



